Find the products and resources you are looking for!
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
June 23–27, 2020
Meet us at the first virtual meeting of the ISSCR
Stem cells have opened up new possibilities for regenerative medicine and cellular-based therapeutic approaches. As the scientific discoveries advance, the possibility of utilizing human induced pluripotent stem cells (hiPSCs) in the clinical practice becomes closer and the first induced pluripotent stem cell (iPSC) derivatives are undergoing clinical trials. These great achievements would not be possible without a parallel improvement and refinement of translational research solutions.
Participate in our Innovation Showcase and listen to the experts giving insights on their latest developments in moving pluripotent stem cell (PSC) research towards therapeutic applications.
Visit our virtual booth to get to know our cutting-edge technologies for stem cell culture, cell sorting, and imaging. We would be happy to explain them to you in detail or answer your questions via the live chat.
From bench to bedside – pluripotent stem cell differentiation.
Thursday, June 25, 2020 | 1:00 p.m.–2:00 p.m. EST
Two speakers present their latest developments in moving PSC research towards therapeutic applications:
Pluripotent stem cell (PSC) research is rapidly moving towards therapeutic applications. This clinical outlook requires the implementation of workflows which ensure a seamless transition from bench to bedside.
Sebastian Knoebel will present recent developments with regards to PSC maintenance, characterization, and the latest innovations in PSC differentiation. Specifically, he will highlight how PSC workflows such as expansion and differentiation can be implemented using the new CliniMACS Prodigy® Adherent Cell Culture System together with high-quality cell culture reagents and reliable quality control solutions.
Agnete Kirkeby will give a special focus on strategies pursued in a H2020 consortium to bring hESC-derived cell products to clinical trial for Parkinson’s disease (PD). The treatment of PD has for more than 50 years relied on dopaminergic therapies that are effective early in the disease, but which are limited by severe side effects. Restoring the lost dopaminergic innervation of the striatum would represent a major advance in treating PD. Methods for producing authentic midbrain dopaminergic neurons from pluripotent cells have advanced to a stage which makes it possible to efficiently produce dopaminergic progenitors at a high purity and quality.
Find out about our latest product developments and applications in our poster presentation.
Visit our virtual booth to have a quick overview of our solutions for stem cell culture,
cell sorting, and imaging.
Do you have a question? Simply use the chat function after entering our virtual booth at ISSCR 2020 Virtual. We will be happy to answer all your queries.
Our experts will be online on:
Wednesday, June 24 | 8:30 a.m.–5:30 p.m. EDT
Thursday, June 25 | 11:00 a.m.–7:00 p.m. EDT
Friday, June 26 | 1:00 p.m.–9:00 p.m. EDT
Saturday, June 27 | 7:30 a.m.–1:00 p.m. EDT
Join the "CliniMACS Prodigy® Adherent Cell Culture System" virtual demo and learn how to automate adherent stem cell manufacturing in a closed system.
Choice of two dates:
June 25, 2020
Berlin, Germany (GMT+02:00) − 6:00 PM CET
New York, NY, USA (GMT-04:00) − 12:00 PM EDT
San Francisco, CA, USA (GMT-07:00) − 9:00 AM PST
June 26, 2020
Berlin, Germany (GMT+02:00) − 10:00 AM CET
London, United Kingdom (GMT+01:00) − 9:00 AM GMT
Singapore, Singapore (GMT+08:00) − 4:00 PM
Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.